美股三大指数集体低开，抗肥胖药物开发商Metsera涨超57%

Market Overview - The three major U.S. stock indices opened lower, with the Dow Jones down 0.38%, the Nasdaq down 0.12%, and the S&P 500 down 0.22% [1] Company Highlights - Metsera, a developer of anti-obesity drugs, surged over 57% following reports that Pfizer is close to acquiring the company for $7.3 billion [1] - ASML rose over 3% as Morgan Stanley significantly raised its target price from €600 to €950 [1] - Snap experienced an increase of over 10% [1] - Premier, a healthcare company, saw its stock rise over 8% [1] - Harmony Gold gained over 4% [1] - Baidu's stock increased by over 3% [1]